Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation

Not Applicable

Completed

• Conditions: Cardiopulmonary Endurance; Pacemaker DDD
• Interventions: Other: Supervise and guide regular exercise

• Registration Number: NCT04957771
• Lead Sponsor: Peking University Third Hospital

Brief Summary

The purpose of this study is to observe the changes of cardiopulmonary endurance in patients with pacemaker implantation after long-term exercise, to explore the significance of exercise on patients with pacemaker implantation, and to analyze the difference of the effect of exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-08
• Study Start: 2019-08-01
• Primary Completion: 2020-07-31
• Study Completion: 2020-07-31
• Study First Submitted: 2021-06-27
• Study First Submitted QC: 2021-07-04
• Last Update Submitted: 2021-07-04
• Study First Posted: 2021-07-12
• Last Update Posted: 2021-07-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• 18-75 years old patients with pacemaker implantation for the first time,
• 3-6 months after operation
• stable condition,
• independent walking ability.

Read More

Exclusion Criteria

• Cognitive impairment;
• ICD, CRT / Crtd implanted,
• patients with neurogenic syncope;
• Atrial tachycardia, atrial fibrillation,
• NYHA class II or above,
• difficult to control hypertension;
• Musculoskeletal disease limiting activity
• nervous system disease,
• severe respiratory disease,
• Patients with acute inflammation,
• cancer and other diseases uncontrolled.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Regular exercise group	Supervise and guide regular exercise	-

Primary Outcome Measures

Name	Time	Method
Parameters related to exercise cardiopulmonary assessment	followed up for one year	VO2peak

Trial Locations

Locations (1)

Peking University Third Hospital; 🇨🇳 Beijing, Haidian, China